GNA Biosolutions
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+49 89998207180Website
www.gna-bio.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GNA Biosolutions
GNA Biosolutions is a private molecular diagnostics company located in Germany. Our proprietary PCA technology offers a novel, ultrafast, and cost-effective molecular diagnostic platform that captures and amplifies nucleic acids from complex clinical samples. PCA assays are being developed for a number of therapeutic areas, including infectious diseases and biothreats. The company's first Point of Care product will be utilized for the diagnosis of antibiotic resistant Hospital Acquired Infections (HAIs) and Tuberculosis (TB). PCA technology has not been cleared or approved by European of U.S. regulatory agencies and is currently for research use only.Explore more
GNA Biosolutions Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GNA Biosolutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once GNA Biosolutions has new funding data
Website visits: Recent activity has been detected on your website
Check out if GNA Biosolutions is spiking on competitors!
Click to see if GNA Biosolutions had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at GNA Biosolutions
Check if GNA Biosolutions has recently received funding, and reach out quickly before it becomes old news!
GNA Biosolutions, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on GNA Biosolutions recently announced quarterly report
Product Launch: Get notified when GNA Biosolutions launches new products
Recommended Actions
Reach out to Masked Content who joined GNA Biosolutions as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
GNA Biosolutions is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GNA Biosolutions is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GNA Biosolutions.
GNA Biosolutions financials insights
Gather financial insights about GNA Biosolutions, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series B
$6.7M
2019
Series C
$13.5M
GNA Biosolutions Tech Stack
A closer look at the technologies used by GNA Biosolutions
GNA Biosolutions News & Media
GNA Biosolutions Raises $13.5M in Series C Financing
GNA Biosolutions GmbH, a Munich, Germany-based molecular diagnostics company based in Germany, closed a $13.5M round of financing. Backers included new investors GreyBird Ventures, Occident, and Wachtumsfonds Bayern, and existing investors SHS Gesellschaft für Beteiligungsmanagement, Robert Bosch Venture Capital, UVC Partners, Mey Capital Matrix, KfW, and btov Partners. Tom Miller, partner at GreyBird Ventures, was […] The post GNA Biosolutions Raises $13.5M in Series C Financing appeared first
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GNA Biosolutions
Sign Up For FreeTo access detailed company insights
GNA Biosolutions is a private molecular diagnostics company located in Germany. Our proprietary PCA technology offers a novel, ultrafast, and cost-effective molecular diagnostic platform that captures and amplifies nucleic acids from complex clinical samples. PCA assays are being developed for a number of therapeutic areas, including infectious dis... Read More
